206 related articles for article (PubMed ID: 17668876)
1. Hepatitis C virus escape from the interferon regulatory factor 3 pathway by a passive and active evasion strategy.
Binder M; Kochs G; Bartenschlager R; Lohmann V
Hepatology; 2007 Nov; 46(5):1365-74. PubMed ID: 17668876
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon.
Breiman A; Grandvaux N; Lin R; Ottone C; Akira S; Yoneyama M; Fujita T; Hiscott J; Meurs EF
J Virol; 2005 Apr; 79(7):3969-78. PubMed ID: 15767399
[TBL] [Abstract][Full Text] [Related]
3. Limited suppression of the interferon-beta production by hepatitis C virus serine protease in cultured human hepatocytes.
Dansako H; Ikeda M; Kato N
FEBS J; 2007 Aug; 274(16):4161-76. PubMed ID: 17651439
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C Virus Infection Is Inhibited by a Noncanonical Antiviral Signaling Pathway Targeted by NS3-NS4A.
Vazquez C; Tan CY; Horner SM
J Virol; 2019 Dec; 93(23):. PubMed ID: 31534039
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus-encoded small RNA induces IL-10 through RIG-I-mediated IRF-3 signaling.
Samanta M; Iwakiri D; Takada K
Oncogene; 2008 Jul; 27(30):4150-60. PubMed ID: 18362887
[TBL] [Abstract][Full Text] [Related]
6. Regulation of CXCL-8 (interleukin-8) induction by double-stranded RNA signaling pathways during hepatitis C virus infection.
Wagoner J; Austin M; Green J; Imaizumi T; Casola A; Brasier A; Khabar KS; Wakita T; Gale M; Polyak SJ
J Virol; 2007 Jan; 81(1):309-18. PubMed ID: 17035306
[TBL] [Abstract][Full Text] [Related]
7. Expression of an IRF-3 fusion protein and mouse estrogen receptor, inhibits hepatitis C viral replication in RIG-I-deficient Huh 7.5 cells.
Yao L; Yan X; Dong H; Nelson DR; Liu C; Li X
Virol J; 2011 Sep; 8():445. PubMed ID: 21936899
[TBL] [Abstract][Full Text] [Related]
8. Induction of IRF-3 and IRF-7 phosphorylation following activation of the RIG-I pathway.
Paz S; Sun Q; Nakhaei P; Romieu-Mourez R; Goubau D; Julkunen I; Lin R; Hiscott J
Cell Mol Biol (Noisy-le-grand); 2006 May; 52(1):17-28. PubMed ID: 16914100
[TBL] [Abstract][Full Text] [Related]
9. DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.
Grünvogel O; Esser-Nobis K; Reustle A; Schult P; Müller B; Metz P; Trippler M; Windisch MP; Frese M; Binder M; Fackler O; Bartenschlager R; Ruggieri A; Lohmann V
J Virol; 2015 Oct; 89(20):10548-68. PubMed ID: 26269178
[TBL] [Abstract][Full Text] [Related]
10. Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling.
Foy E; Li K; Sumpter R; Loo YM; Johnson CL; Wang C; Fish PM; Yoneyama M; Fujita T; Lemon SM; Gale M
Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2986-91. PubMed ID: 15710892
[TBL] [Abstract][Full Text] [Related]
11. Functional and therapeutic analysis of hepatitis C virus NS3.4A protease control of antiviral immune defense.
Johnson CL; Owen DM; Gale M
J Biol Chem; 2007 Apr; 282(14):10792-803. PubMed ID: 17289677
[TBL] [Abstract][Full Text] [Related]
12. Restoration of the activated Rig-I pathway in hepatitis C virus (HCV) replicon cells by HCV protease, polymerase, and NS5A inhibitors in vitro at clinically relevant concentrations.
Kalkeri G; Lin C; Gopilan J; Sloan K; Rijnbrand R; Kwong AD
Antimicrob Agents Chemother; 2013 Sep; 57(9):4417-26. PubMed ID: 23836176
[TBL] [Abstract][Full Text] [Related]
13. Retinoic acid inducible gene-I (RIG-I) signaling of hepatic stellate cells inhibits hepatitis C virus replication in hepatocytes.
Wang Y; Ye L; Wang X; Li J; Song L; Ho W
Innate Immun; 2013; 19(2):193-202. PubMed ID: 23060457
[TBL] [Abstract][Full Text] [Related]
14. Pathogen-Associated Molecular Pattern Recognition of Hepatitis C Virus Transmitted/Founder Variants by RIG-I Is Dependent on U-Core Length.
Kell A; Stoddard M; Li H; Marcotrigiano J; Shaw GM; Gale M
J Virol; 2015 Nov; 89(21):11056-68. PubMed ID: 26311867
[TBL] [Abstract][Full Text] [Related]
15. Antiviral suppression vs restoration of RIG-I signaling by hepatitis C protease and polymerase inhibitors.
Liang Y; Ishida H; Lenz O; Lin TI; Nyanguile O; Simmen K; Pyles RB; Bourne N; Yi M; Li K; Lemon SM
Gastroenterology; 2008 Nov; 135(5):1710-1718.e2. PubMed ID: 18725224
[TBL] [Abstract][Full Text] [Related]
16. EFTUD2 Is a Novel Innate Immune Regulator Restricting Hepatitis C Virus Infection through the RIG-I/MDA5 Pathway.
Zhu C; Xiao F; Hong J; Wang K; Liu X; Cai D; Fusco DN; Zhao L; Jeong SW; Brisac C; Chusri P; Schaefer EA; Zhao H; Peng LF; Lin W; Chung RT
J Virol; 2015 Jul; 89(13):6608-18. PubMed ID: 25878102
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus NS4B protein targets STING and abrogates RIG-I-mediated type I interferon-dependent innate immunity.
Nitta S; Sakamoto N; Nakagawa M; Kakinuma S; Mishima K; Kusano-Kitazume A; Kiyohashi K; Murakawa M; Nishimura-Sakurai Y; Azuma S; Tasaka-Fujita M; Asahina Y; Yoneyama M; Fujita T; Watanabe M
Hepatology; 2013 Jan; 57(1):46-58. PubMed ID: 22911572
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms.
Nandakumar R; Finsterbusch K; Lipps C; Neumann B; Grashoff M; Nair S; Hochnadel I; Lienenklaus S; Wappler I; Steinmann E; Hauser H; Pietschmann T; Kröger A
Gastroenterology; 2013 Dec; 145(6):1414-23.e1. PubMed ID: 23973921
[TBL] [Abstract][Full Text] [Related]
19. Peripheral B cells may serve as a reservoir for persistent hepatitis C virus infection.
Ito M; Masumi A; Mochida K; Kukihara H; Moriishi K; Matsuura Y; Yamaguchi K; Mizuochi T
J Innate Immun; 2010; 2(6):607-17. PubMed ID: 20714117
[TBL] [Abstract][Full Text] [Related]
20. HepG2 cells mount an effective antiviral interferon-lambda based innate immune response to hepatitis C virus infection.
Israelow B; Narbus CM; Sourisseau M; Evans MJ
Hepatology; 2014 Oct; 60(4):1170-9. PubMed ID: 24833036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
